ACHONDROPLASIA
|
AGAMMAGLOBULINEMIA 6
|
AND CATARACTS
|
ANTLEY-BIXLER SYNDROME WITHOUT GENI
|
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STE
|
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS,
|
AORTIC ANEURYSM, FAMILIAL THORACIC 7 (AAT7)
|
BLOOD GROUP--LUTHERAN NULL
|
BLOOD GROUP--OK
|
CARDIOMYOPATHY, DILATED, 1CC
|
CARDIOMYOPATHY, DILATED, 1G
|
CARDIOMYOPATHY, DILATED, 1KK
|
CARDIOMYOPATHY, DILATED, 1MM
|
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 22, INCLUDED
|
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4
|
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4, INCLUDED;;
|
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 4
|
CD64 DEFICIENCY, FAMILIAL
|
CD8 DEFICIENCY, FAMILIAL
|
CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B
|
CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B, INCLUDED
|
CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B, WITH FOCALLY FOLDED MYELIN SHEATHS
|
CHARCOT-MARIE-TOOTH DISEASE, TYPE 2I
|
CHARCOT-MARIE-TOOTH DISEASE, TYPE 2J
|
COLORECTAL CANCER, SOMATIC
|
CONGENITAL SHORT BOWEL SYNDROME
|
CRANIOSYNOSTOSIS, NONCLASSIFIABLE AUTOSOMAL DOMINANT, INCLUDED;;
|
CRANIOSYNOSTOSIS, NONSYNDROMIC UNICORONAL
|
CROUZON SYNDROME
|
CROUZON SYNDROME, INCLUDED
|
CYSTIC FIBROSIS,
|
DEAFNESS, AUTOSOMAL DOMINANT 4B
|
DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT
|
ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1
|
ESOPHAGEAL CARCINOMA, SOMATIC
|
GASTRIC CANCER, SOMATIC, INCLUDED
|
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS
|
HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,
|
HYDROCEPHALUS DUE TO STENOSIS OF THE AQUEDUCT OF SYLVIUS (HSAS)
|
HYPOCHONDROPLASIA
|
HYPOCHONDROPLASIA, INCLUDED
|
HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA, SUSCEPTIBILITY TO
|
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA, SUSCEPTIBILITY
|
HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA, SUSCEPTIBILITY TO
|
HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT
|
IGG RECEPTOR I, PHAGOCYTIC, FAMILIAL DEFICIENCY OF
|
INCLUDED
|
JACKSON-WEISS SYNDROME
|
JACKSON-WEISS SYNDROME, INCLUDED
|
JACKSON-WEISS SYNDROME, INCLUDED;;
|
LEFT VENTRICULAR NONCOMPACTION 10, I
|
LETHAL CONGENITAL CONTRACTURE SYNDROME 4
|
LUPUS NEPHRITIS, SUSCEPTIBILITY TO
|
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A
|
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING,
|
MENTAL RETARDATION, APHASIA, SHUFFLING GAIT, AND ADDUCTED THUMBS SYNDROME (MASA)
|
NARCOLEPSY 7
|
NEPHROTIC SYNDROME 1 (NPHS1)
|
NEPHROTIC SYNDROME, TYPE 1
|
NEUROPATHY, CONGENITAL HYPOMYELINATING, AUTOSOMAL DOMINANT
|
OSTEOGLOPHONIC DYSPLASIA
|
OVARIAN CANCER, SOMATIC
|
PFEIFFER SYNDROME
|
PFEIFFER SYNDROME, INCLUDED
|
PFEIFFER SYNDROME, INCLUDED;;
|
PFEIFFER SYNDROME, TYPE III
|
PSEUDOMONAS AERUGINOSA, SUSCEPTIBILITY TO CHRONIC INFECTION BY, IN
|
RADIN BLOOD GROUP ANTIGEN
|
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE
|
ROUSSY-LEVY SYNDROME
|
SCAPHOCEPHALY AND AXENFELD-RIEGER AN
|
SCIANNA BLOOD GROUP SYSTEM, SC:-1,2
|
SCIANNA BLOOD GROUP SYSTEM, STAR ANTIGEN
|
SPONDYLOEPIMETAPHYSEAL DYSPLASIA AGGRECAN TYPE (SEMD-ACAN)
|
THREE M SYNDROME 2
|
TO
|
TRIGONOCEPHALY 1
|
UROFACIAL SYNDROME 2
|
VARIANT OF UNKNOWN SIGNIFICANCE
|
WITH MENTAL RETARDATION
|
WITH OR WITHOUT MENTAL RETARDATION
|